Ergomed plc
Save
771.71M
Market cap
48.14x
Current P/E
27.55x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies.
Similar securities
Based on sector and market capitalization
Report issue